Literature DB >> 9820183

Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations.

J Bernardino1, M Gerbault-Seureau, B Zafrani, Y Dericke, E Boudou, H Magdelenat, B Dutrillaux.   

Abstract

A correlation analysis was performed on 223 breast carcinomas to assess the relationships between gene amplification, karyotypic and clinicopathological features. Homogeneously staining region (HSR) is the most frequent form of amplification found in breast cancer. HSR-containing tumours accounted for 60% of the cases. Although up to 40% of tumours with slightly altered karyotype contained HSRs, an excess of HSRs was found within the tumours whose karyotype showed the highest rates of rearranged chromosomes. HSRs were also found to be particularly frequent in small tumours of high histological grade and with a low expression of progesterone receptors. An excess of HSRs seems to be observed in younger patients, however, significant correlation could be demonstrated only for patients below 55 years and below 60 years, compared with older ones. With a 120-month follow-up for 152 patients, a significant association between the presence of HSRs and a shortened overall survival was observed. Altogether, the presence of HSRs appears to be a good indicator of poor prognosis. Further studies are needed to determine whether amplification of specific genes or cell ability to amplify is the most important parameter for tumour progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820183      PMCID: PMC2063008          DOI: 10.1038/bjc.1998.657

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Breast cancer genetic evolution: I. Data from cytogenetics and DNA content.

Authors:  B Dutrillaux; M Gerbault-Seureau; Y Remvikos; B Zafrani; M Prieur
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

2.  Cytogenetic study of breast cancer: clinicopathologic significance of homogeneously staining regions in 84 patients.

Authors:  B Zafrani; M Gerbault-Seureau; V Mosseri; B Dutrillaux
Journal:  Hum Pathol       Date:  1992-05       Impact factor: 3.466

3.  Proto-oncogene amplification and homogeneously staining regions in human breast carcinomas.

Authors:  C Saint-Ruf; M Gerbault-Seureau; E Viegas-Péquignot; B Zafrani; R Cassingena; B Dutrillaux
Journal:  Genes Chromosomes Cancer       Date:  1990-05       Impact factor: 5.006

4.  Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes.

Authors:  C Saint-Ruf; M Gerbault-Seureau; E Viegas-Péquignot; B Zafrani; B Malfoy; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1991-03

5.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

6.  C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.

Authors:  M Noguchi; N Koyasaki; N Ohta; H Kitagawa; M Earashi; M Thomas; I Miyazaki; Y Mizukami
Journal:  Cancer       Date:  1992-06-15       Impact factor: 6.860

7.  Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression.

Authors:  H Magdelenat; M Gerbault-Seureau; C Laine-Bidron; M Prieur; B Dutrillaux
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 8.  Genetic alterations in breast cancer.

Authors:  I Bièche; R Lidereau
Journal:  Genes Chromosomes Cancer       Date:  1995-12       Impact factor: 5.006

9.  Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis.

Authors:  Y Remvikos; M Gerbault-Seureau; H Magdelénat; M Prieur; B Dutrillaux
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Rearrangement of chromosome 1p in breast cancer correlates with poor prognostic features.

Authors:  P J Hainsworth; K L Raphael; R G Stillwell; R C Bennett; O M Garson
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more
  1 in total

1.  An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.

Authors:  Françoise Bonnet; Mickael Guedj; Natalie Jones; Sana Sfar; Véronique Brouste; Nabila Elarouci; Guillaume Banneau; Béatrice Orsetti; Charlotte Primois; Christine Tunon de Lara; Marc Debled; Isabelle de Mascarel; Charles Theillet; Nicolas Sévenet; Aurélien de Reynies; Gaëtan MacGrogan; Michel Longy
Journal:  BMC Med Genomics       Date:  2012-11-27       Impact factor: 3.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.